Doctors back limits on advertising for new drugs
I agree wholeheartedly. The nation's leading group of general internal medicine physicians has taken the U.S. Food and Drug Administration to task over drug safety and urged the agency to adopt a raft...
View ArticleWill there be a crackdown on pharmaceutical data mining?
I sure hope so. Because the ability of pharmaceuticals to find out how often doctors prescribe which medications allows those pharmaceuticals to engage in all sorts of shenanigans, like finding...
View ArticleMassachusetts wants to return to the bad old days of pharmaceutical gifts
I think one of the most dangerous practices out there is that of pharmaceutical companies wooing doctors with free gifts and meals. In states where it is legal, you have a group of sales reps (most of...
View ArticleGlaxoSmithKline Sales Rep Bonuses Are Tied To Values, Not Sales
I’ll be honest with you. I don’t trust pharmaceutical sales reps. Few of them are medical doctors, but they tell doctors which drugs should be prescribed for which patients. Traditionally, their...
View ArticlePatients Are Concerned About Doctors & Pharmaceuticals
A little skepticism is a healthy thing: Many patients taking prescription drugs believe that pharmaceutical companies have too much influence over their physicians’ prescribing practices, according to...
View ArticleDr. Elliott On Pharmaceutical Propaganda
I’ve had the opportunity to email Dr. Elliott several times since interviewing him and he’s just an all-around good guy. That sentiment was amplified today when I saw this column on CNN: (CNN) — If...
View ArticleDispute over the names for biosimilars
As reported by DrugStoreNews.com, there has been a lot of discussion in the biotechnology world over the appropriate names of follow-on biologics. “Follow-on biologics,” also known as “biosimilars,”...
View Article
